SuperSonic Imagine introduces UltraFast Doppler technology

NewsGuard 100/100 Score

SuperSonic Imagine, the ultrasound company that pioneered breakthrough ShearWave™ Elastography technology, today announced another major breakthrough in ultrasound imaging: UltraFast™ Doppler. The company, based in Aix-en-Provence, France, unveiled this revolutionary technology at the World Federation for Ultrasound in Medicine and Biology, Euroson and Ultraschall Meeting.

Color Flow Imaging and Pulsed Wave Doppler are well-established ultrasound tools that analyze blood flow and are critical to cardiovascular disease assessment and cancer diagnosis.

On Aixplorer's fully patented UltraFast imaging platform, UltraFast Doppler unites Color Flow Imaging with Pulsed Wave Doppler. The result is never-seen-before ultra-high frame rate Color Flow clips that are up to ten times faster than conventional Color Doppler. Remarkably, the same technology also acquires fully quantifiable Doppler data throughout the Color box, enabling the generation of post-processed Pulsed Wave Doppler spectra from multiple locations in the same image.

These new advances in Doppler technology introduce a new era of flow imaging, workflow efficiency and diagnostic confidence.

Peter Burns, Professor of Medical Biophysics at the University of Toronto and Senior Scientist at Sunnybrook Health Sciences Centre, Toronto commented, "This technology promises to overcome two challenges faced by vascular sonographers every day when they use conventional duplex scanners. First, conventional color frame rates are too low to show real arterial hemodynamics, with pathology often masked by aliasing artifacts and second, the pulsed Doppler examination is a separate and time consuming process of searching for the optimal signal. UltraFast Doppler provides high frame rates, less aliasing and the ability to show spectra at every point in a stored color loop. It provides more accurate flow imaging and will enable more effective workflow in the vascular lab."

In 2008, SuperSonic Imagine made worldwide headlines with its Aixplorer® MultiWave™ Ultrasound System that hit the market with impeccable image quality and an elastography technique never before seen. The Aixplorer is the only system in the world that has ShearWave™ Elastography imaging, the first major innovation in ultrasound since Doppler. This industry leading technology gives real-time, quantitative information about tissue stiffness by measuring and displaying local tissue elasticity on a color-coded map, in kilopascals. The assessment ShearWave Elastography was validated in the largest breast clinical trial ever undertaken by an ultrasound company (1800 lesions, 16 sites around the world) with proven reproducibility and increased ultrasound specificity while maintaining a high sensitivity. ShearWave Elastography has been adopted by physicians around the world as a vital tool to increasing diagnostic precision and confidence.

"ShearWave Elastography brought a new type of information to physicians to improve their diagnostic confidence. Today, with UltraFast Doppler, we are reinventing the Doppler analysis by breaking a 25 year-old rule in ultrasound of having to choose between flow imaging and flow quantification," said Jeremy Bercoff, Scientific Expert and Co-Founder of SuperSonic Imagine. "We are very excited to introduce this new ultrafast technology feature and we are confident it will bring tremendous clinical benefits to physicians."

Comments

The opinions expressed here are the views of the writer and do not necessarily reflect the views and opinions of News Medical.
Post a new comment
Post

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.

You might also like...
Revolutionizing diabetes management with reliable blood glucose monitoring without finger pricking